Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Study of GlucoThera Plus for Peritoneal Dialysis in Children
2022-002684-29Phase 3Active
- Sponsor
- Iperboreal Pharma
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of glucose monohydrate + levocarnitine + sodium chloride + calcium chloride dihydrate + magnesium chloride hexahydrate + sodium lactate in end-stage kidney disease (ESKD), sponsored by Iperboreal Pharma. Primary endpoint: Safety (adverse events, blood pressure, body weight). Started Jan 2023; status: active.
02
Drugs
glucose monohydrate + levocarnitine + sodium chloride + calcium chloride dihydrate + magnesium chloride hexahydrate + sodium lactate
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2022-002684-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002684-29.